(Q57395959)
Statements
In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo (English)
Gunter Schuch
Marcelle Machluf
Georg Bartsch
Masashi Nomi
Henri Richard
1 December 2002